{
    "id": "NGN_Cloze_2026_BATCH300-191-1771351245451",
    "itemType": "standalone",
    "questionType": "clozeDropdown",
    "caseId": null,
    "seed": "BATCH-300-191-1771351245451",
    "cjjm": "takeActions",
    "difficulty": 4,
    "stem": "The nurse in a neurology clinic receives a call from a 38-year-old client with relapsing-remitting multiple sclerosis (MS). The client reports a 3-day history of increasing numbness in the left leg, right-sided blurred vision, and debilitating fatigue. The nurse suspects an MS relapse.",
    "body": "The nurse is developing a plan of care for this client experiencing a suspected MS relapse. The nurse should anticipate implementing the following orders.\n\nThe client will be scheduled for a(n) **[1]** to confirm new inflammatory activity.\nThe nurse will prepare to administer **[2]** to manage the acute exacerbation.\nThe nurse should educate the client that this medication works by **[3]**.\nTo manage the new-onset fatigue, the nurse should recommend **[4]**.\nThe nurse should also screen the client for **[5]** as a common comorbidity exacerbated by a relapse.",
    "clozeDropdowns": [
        {
            "blankId": "1",
            "options": [
                {
                    "id": "opt_1_1",
                    "text": "MRI of the brain and spinal cord with gadolinium"
                },
                {
                    "id": "opt_1_2",
                    "text": "lumbar puncture for CSF analysis"
                },
                {
                    "id": "opt_1_3",
                    "text": "CT scan of the head without contrast"
                },
                {
                    "id": "opt_1_4",
                    "text": "evoked potential studies"
                }
            ]
        },
        {
            "blankId": "2",
            "options": [
                {
                    "id": "opt_2_1",
                    "text": "oral baclofen"
                },
                {
                    "id": "opt_2_2",
                    "text": "high-dose intravenous methylprednisolone"
                },
                {
                    "id": "opt_2_3",
                    "text": "a new disease-modifying therapy (DMT)"
                },
                {
                    "id": "opt_2_4",
                    "text": "plasmapheresis"
                }
            ]
        },
        {
            "blankId": "3",
            "options": [
                {
                    "id": "opt_3_1",
                    "text": "blocking nerve impulses that cause muscle spasticity"
                },
                {
                    "id": "opt_3_2",
                    "text": "preventing future relapses over the long term"
                },
                {
                    "id": "opt_3_3",
                    "text": "suppressing the inflammatory response in the central nervous system"
                },
                {
                    "id": "opt_3_4",
                    "text": "removing harmful antibodies from the blood plasma"
                }
            ]
        },
        {
            "blankId": "4",
            "options": [
                {
                    "id": "opt_4_1",
                    "text": "complete bed rest to conserve all energy"
                },
                {
                    "id": "opt_4_2",
                    "text": "balancing periods of activity with rest"
                },
                {
                    "id": "opt_4_3",
                    "text": "starting a high-intensity interval training program"
                },
                {
                    "id": "opt_4_4",
                    "text": "increasing consumption of caffeinated beverages"
                }
            ]
        },
        {
            "blankId": "5",
            "options": [
                {
                    "id": "opt_5_1",
                    "text": "depression"
                },
                {
                    "id": "opt_5_2",
                    "text": "urinary tract infection"
                },
                {
                    "id": "opt_5_3",
                    "text": "hypothyroidism"
                },
                {
                    "id": "opt_5_4",
                    "text": "seizure activity"
                }
            ]
        }
    ],
    "answer": [
        "opt_1_1",
        "opt_2_2",
        "opt_3_3",
        "opt_4_2",
        "opt_5_1"
    ],
    "answerBreakdown": {
        "findings": [
            {
                "key": "Client Information",
                "value": "38-year-old with relapsing-remitting MS."
            },
            {
                "key": "Symptoms",
                "value": "3-day history of increasing numbness in left leg, right-sided blurred vision, and debilitating fatigue."
            },
            {
                "key": "Suspected Diagnosis",
                "value": "MS relapse (exacerbation)."
            }
        ],
        "rationales": [
            {
                "optionId": "opt_1_1",
                "rationale": "Correct. An MRI with gadolinium contrast is the gold standard for confirming an MS relapse. Active inflammatory lesions will enhance (light up) with the gadolinium dye, providing objective evidence of a new central nervous system (CNS) event.",
                "points": 1
            },
            {
                "optionId": "opt_1_2",
                "rationale": "Incorrect. A lumbar puncture to analyze cerebrospinal fluid (CSF) for oligoclonal bands is primarily used for the initial diagnosis of MS, not for confirming an acute relapse in a client with a known diagnosis.",
                "points": 0
            },
            {
                "optionId": "opt_1_3",
                "rationale": "Incorrect. CT scans are not sensitive enough to visualize the demyelinating plaques characteristic of MS. MRI is the required imaging modality.",
                "points": 0
            },
            {
                "optionId": "opt_1_4",
                "rationale": "Incorrect. Evoked potential studies measure the speed of nerve conduction and can help diagnose MS by showing slowed nerve signals. However, they are not the primary tool for confirming an acute, active relapse; an MRI is used for that purpose.",
                "points": 0
            },
            {
                "optionId": "opt_2_1",
                "rationale": "Incorrect. Baclofen is a muscle relaxant used to manage chronic spasticity in MS. It does not treat the underlying inflammation of an acute relapse.",
                "points": 0
            },
            {
                "optionId": "opt_2_2",
                "rationale": "Correct. High-dose intravenous corticosteroids, such as methylprednisolone, are the first-line treatment for acute MS relapses. They reduce inflammation in the CNS, which can shorten the duration and severity of the relapse.",
                "points": 1
            },
            {
                "optionId": "opt_2_3",
                "rationale": "Incorrect. Disease-modifying therapies (DMTs) are used for long-term management to reduce the frequency and severity of relapses. They do not treat an acute exacerbation.",
                "points": 0
            },
            {
                "optionId": "opt_2_4",
                "rationale": "Incorrect. Plasmapheresis (plasma exchange) is a second-line therapy reserved for severe relapses that do not respond to high-dose corticosteroids. It is not the initial intervention.",
                "points": 0
            },
            {
                "optionId": "opt_3_1",
                "rationale": "Incorrect. This describes the mechanism of action for antispasmodic medications like baclofen, not corticosteroids.",
                "points": 0
            },
            {
                "optionId": "opt_3_2",
                "rationale": "Incorrect. This describes the goal of disease-modifying therapies (DMTs), which modulate the immune system over time. Corticosteroids provide short-term, acute anti-inflammatory effects.",
                "points": 0
            },
            {
                "optionId": "opt_3_3",
                "rationale": "Correct. Corticosteroids like methylprednisolone work by exerting a potent anti-inflammatory and immunosuppressive effect, which reduces edema and inflammation at the sites of demyelination in the CNS.",
                "points": 1
            },
            {
                "optionId": "opt_3_4",
                "rationale": "Incorrect. This describes the mechanism of plasmapheresis, which physically removes antibodies and other inflammatory mediators from the blood.",
                "points": 0
            },
            {
                "optionId": "opt_4_1",
                "rationale": "Incorrect. Prolonged bed rest can lead to deconditioning, muscle atrophy, and increased fatigue. It is generally discouraged.",
                "points": 0
            },
            {
                "optionId": "opt_4_2",
                "rationale": "Correct. Energy conservation is a crucial strategy for managing MS fatigue. This involves planning activities, taking scheduled rest periods, and avoiding overexertion to maintain functional ability.",
                "points": 1
            },
            {
                "optionId": "opt_4_3",
                "rationale": "Incorrect. High-intensity exercise can significantly worsen fatigue and other MS symptoms, particularly during an acute relapse. Gentle, graded exercise may be appropriate, but not high-intensity training.",
                "points": 0
            },
            {
                "optionId": "opt_4_4",
                "rationale": "Incorrect. While caffeine can provide a temporary boost, overuse can disrupt sleep patterns and lead to a crash, ultimately worsening the cycle of fatigue. It is not a recommended primary management strategy.",
                "points": 0
            },
            {
                "optionId": "opt_5_1",
                "rationale": "Correct. Depression is a highly prevalent comorbidity in clients with MS. The physical, emotional, and social challenges of a relapse can trigger or worsen depressive symptoms. Routine screening is an essential part of comprehensive nursing care.",
                "points": 1
            },
            {
                "optionId": "opt_5_2",
                "rationale": "Incorrect. A urinary tract infection (UTI) is a common *trigger* for a pseudo-exacerbation (a temporary worsening of symptoms due to infection or fever, not new demyelination). The question asks about screening for a common *comorbidity*, making depression the better answer.",
                "points": 0
            },
            {
                "optionId": "opt_5_3",
                "rationale": "Incorrect. While autoimmune disorders can co-occur, hypothyroidism is not as common or directly linked to MS exacerbations as depression. The symptoms of MS are more likely to exacerbate mood disorders.",
                "points": 0
            },
            {
                "optionId": "opt_5_4",
                "rationale": "Incorrect. While seizures can occur in clients with MS due to cortical lesions, they are not as common a comorbidity as depression. Screening for mood disorders is a higher priority during a relapse.",
                "points": 0
            }
        ]
    },
    "scoring": {
        "type": "dichotomous",
        "points": 1,
        "perCloze": true,
        "totalPoints": 5
    }
}